深圳市海王生物工程股份有限公司2025年第一次临时股东大会决议公告

Group 1 - The company held its first extraordinary general meeting of shareholders in 2025 on April 18, 2025, with both on-site and online voting options available [3][4][5] - A total of 459 shareholders attended the meeting, representing 1,239,732,848 shares, which is 47.1180% of the total voting shares [6][7] - The meeting approved several resolutions, including financial assistance for 2025, the extension of guarantees, and the application for comprehensive bank credit [9][10][11][13] Group 2 - The company reported a total of 41,821.18 million RMB in newly added litigation and arbitration cases, which accounts for 9.92% of the latest audited net assets [17] - The amount involved in litigation where the company is the plaintiff is approximately 38,457.08 million RMB, while the amount where the company is the defendant is 3,364.10 million RMB [17][20] - The company confirmed that there are no undisclosed significant litigation or arbitration matters that exceed 10% of the latest audited net assets [18][19]